• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Elizabeth H. Baldini, MD, MPH


  • Parikh RB, Cronin AM, Kozono DE, Oxnard GR, Mak RH, Jackman DM, Lo PC, Baldini EH, Johnson BE, Chen AB.Definitive Primary Therapy in Patients Presenting With Oligometastatic Non-Small Cell Lung Cancer.Int J Radiat Oncol Biol Phys. 2014 May 24.
  • Baldini EH, Raut C.Radiation Therapy for Extremity Soft Tissue Sarcoma: In the Absence of a Clear Survival Benefit, Why Do We Give It?.Ann Surg Oncol. 2014 May 17.
  • Coroller TP, Mak RH, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FL, Hermann G, Kozono D, Mannarino E, Molodowitch C, Wee JO, Sher DJ, Killoran JH.Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.PLoS ONE. 2014;9(4):e94859.
  • Gazula A, Baldini EH, Chen A, Kozono D.Comparison of once and twice daily radiotherapy for limited stage small-cell lung cancer.Lung. 2014 Feb;192(1):151-8.
  • Keung EZ, Hornick JL, Bertagnolli MM, Baldini EH, Raut CP.Predictors of outcomes in patients with primary retroperitoneal dedifferentiated liposarcoma undergoing surgery.J Am Coll Surg. 2014 Feb;218(2):206-17.
  • Chirieac LR, Barletta JA, Yeap BY, Richards WG, Tilleman T, Bueno R, Baldini EH, Godleski J, Sugarbaker DJ.Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma.J Clin Oncol. 2013 Dec 20;31(36):4544-9.
  • Burt BM, Ali SO, DaSilva MC, Yeap BY, Richards WG, Baldini EH, Sugarbaker DJ.Clinical indications and results after chest wall resection for recurrent mesothelioma.J Thorac Cardiovasc Surg. 2013 Dec;146(6):1373-9; discussion 1379-80.
  • Khandekar MJ, Raut CP, Hornick JL, Wang Q, Alexander BM, Baldini EH.Paratesticular Liposarcoma: Unusual Patterns of Recurrence and Importance of Margins.Ann Surg Oncol. 2013 Apr 17.
  • Baldini EH, Lapidus MR, Wang Q, Manola J, Orgill DP, Pomahac B, Marcus KJ, Bertagnolli MM, Devlin PM, George S, Abraham J, Ferrone ML, Ready JE, Raut CP.Predictors for major wound complications following preoperative radiotherapy and surgery for soft-tissue sarcoma of the extremities and trunk: importance of tumor proximity to skin surface.Ann Surg Oncol. 2013 May;20(5):1494-9.
  • Sugarbaker DJ, Gill RR, Yeap BY, Wolf AS, DaSilva MC, Baldini EH, Bueno R, Richards WG.Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-63.
  • Rusch V, Baldini EH, Bueno R, De Perrot M, Flores R, Hasegawa S, Klepetko W, Krug L, Lang-Lazdunski L, Pass H, Weder W, Sugarbaker DJ, .The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-10.
  • Bahig H, Roberge D, Bosch W, Levin W, Petersen I, Haddock M, Freeman C, Delaney TF, Abrams RA, Indelicato DJ, Baldini EH, Hitchcock Y, Kirsch DG, Kozak KR, Wolfson A, Wang D.Agreement Among RTOG Sarcoma Radiation Oncologists in Contouring Suspicious Peritumoral Edema for Preoperative Radiation Therapy of Soft Tissue Sarcoma of the Extremity.Int J Radiat Oncol Biol Phys. 2013 Mar 5.
  • McBride SM, Raut CP, Lapidus M, Devlin PM, Marcus KJ, Bertagnolli M, George S, Baldini EH.Locoregional Recurrence After Preoperative Radiation Therapy for Retroperitoneal Sarcoma: Adverse Impact of Multifocal Disease and Potential Implications of Dose Escalation.Ann Surg Oncol. 2013 Feb 8.
  • Morgan EA, Kozono DE, Wang Q, Mery CM, Butrynski JE, Baldini EH, George S, Nascimento AF, Raut CP.Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy.Ann Surg Oncol. 2012 Nov;19(12):3801-8.
  • Look Hong NJ, Pandalai PK, Hornick JL, Shekar PS, Harmon DC, Chen YL, Butrynski JE, Baldini EH, Raut CP.Cardiac angiosarcoma management and outcomes: 20-year single-institution experience.Ann Surg Oncol. 2012 Aug;19(8):2707-15.
  • Haglund KE, Raut CP, Nascimento AF, Wang Q, George S, Baldini EH.Recurrence Patterns and Survival for Patients with Intermediate- and High-Grade Myxofibrosarcoma.Int J Radiat Oncol Biol Phys. 2010 Oct 15.
  • Abraham JA, Baldini EH, Butrynski JE.Management of adult soft-tissue sarcoma of the extremities and trunk.Expert Rev Anticancer Ther. 2010 Feb;10(2):233-48.
  • Baldini EH.Radiation therapy options for malignant pleural mesothelioma.Semin Thorac Cardiovasc Surg. 2009;21(2):159-63. Review.
  • Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, J√§nne PA, Johnson BE, Allen AM.Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.Cancer. 2009 Sep 15;115(18):4156-66.
  • Lawenda BD,Arnold MG,Tokarz VA,Silverstein JR,Busse PM,McIntyre JF,Deschler DG,Baldini EH,Kachnic LA.Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.Ear Nose Throat J. 2008 Nov;87(11):634-43. Review.
  • Arlot-Bonnemains Y, Baldini E, Martin B, Delcros JG, Toller M, Curcio F, Ambesi-Impiombato F, D'Armiento M, Ulisse S.Effects of the Aurora kinases inhibitor VX-680 on anaplastic thyroid cancer derived cell lines.Endocr Relat Cancer. 2008 Jun;15(2):559-68.
  • Schivazappa C, Berto P, Baldini E, Barni S, Dauria G, Cortesi E.[Cost-effectiveness of oral ibandronate, i.v. zoledronic acid and i.v. generic pamidronate in the management of metastatic bone disease in breast cancer patients: two parallel studies].Recenti Prog Med. 2008 Jan;99(1):27-31.
  • Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, Sugarbaker DJ, Bueno R.Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience.Cancer. 2008 Mar 1;112(5):1106-13.
  • Boldrini L, Gisfredi S, Ursino S, Camacci T, Baldini E, Melfi F, Fontanini G.Mutational analysis in cytological specimens of advanced lung adenocarcinoma: a sensitive method for molecular diagnosis.J Thorac Oncol. 2007 Dec;2(12):1086-90.
  • Del Mastro L, Dozin B, Aitini E, Catzeddu T, Baldini E, Contu A, Durando A, Danese S, Cavazzini G, Canavese G, Bruzzi P, Pronzato P, Venturini M.Timing of adjuvant chemotherapy and tamoxifen in women with breast cancer: findings from two consecutive trials of Gruppo Oncologico Nord-Ovest-Mammella Intergruppo (GONO-MIG) Group.Ann Oncol. 2008 Feb;19(2):299-307.
  • Ulisse S, Baldini E, Toller M, Delcros JG, Gueho A, Curcio F, De Antoni E, Giacomelli L, Ambesi-Impiombato FS, Bocchini S, D'Armiento M, Arlot-Bonnemains Y.Transforming acidic coiled-coil 3 and Aurora-A interact in human thyrocytes and their expression is deregulated in thyroid cancer tissues.Endocr Relat Cancer. 2007 Sep;14(3):827-37.
  • Ito H, Hornick JL, Bertagnolli MM, George S, Morgan JA, Baldini EH, Wagner AJ, Demetri GD, Raut CP.Leiomyosarcoma of the inferior vena cava: survival after aggressive management.Ann Surg Oncol. 2007 Dec;14(12):3534-41.
  • Allen AM, Den R, Wong JS, Zurakowski D, Soto R, Jšnne PA, Zellos L, Bueno R, Sugarbaker DJ, Baldini EH.Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy.Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1366-74.
  • Gridelli C, Ferrara C, Guerriero C, Palazzo S, Grasso G, Pavese I, Satta F, Bajetta E, Cortinovis D, Barbieri F, Gebbia V, Grossi F, Novello S, Baldini E, Gasparini G, Latino W, Durante E, Giustini L, Negrini C.Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study.J Thorac Oncol. 2007 Jun;2(6):475-80.
  • Lucchi M, Melfi F, Baldini E, Fontanini G, Boni G, Viti A, Mussi A.Sentinel lymph node mapping: detection of micrometastases by polymerase chain reaction in non-small cell lung cancer.J Thorac Oncol. 2007 May;2(5 Suppl):S37.
  • Allen AM, Czerminska M, Jšnne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH.Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.Int J Radiat Oncol Biol Phys. 2006 Jul 1;65(3):640-5.
  • Novello S, Baldini E.Women and lung cancer.Ann Oncol. 2006 Mar;17 Suppl 2:ii79-82. Review.
  • Mamon HJ, Yeap BY, Jšnne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R.High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.J Clin Oncol. 2005 Mar 1;23(7):1530-7.
  • Cross CK, Berman S, Buswell L, Johnson B, Baldini EH.Prospective study of palliative hypofractionated radiotherapy (8.5 Gy x 2) for patients with symptomatic non-small-cell lung cancer.Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1098-105.
  • Singer S, Demetri GD, Baldini EH, Fletcher CD.Management of soft-tissue sarcomas: an overview and update.Lancet Oncol. 2000 Oct;1:75-85.
  • Esnaola NF, Rubin BP, Baldini EH, Vasudevan N, Demetri GD, Fletcher CD, Singer S.Response to chemotherapy and predictors of survival in adult rhabdomyosarcoma.Ann Surg. 2001 Aug;234(2):215-23.
  • Killoran JH, Baldini EH, Beard CJ, Chin L.A technique for optimization of digitally reconstructed radiographs of the chest in virtual simulation.Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):231-9.
  • Baldini EH, Goldberg J, Jenner C, Manola JB, Demetri GD, Fletcher CD, Singer S.Long-term outcomes after function-sparing surgery without radiotherapy for soft tissue sarcoma of the extremities and trunk.J Clin Oncol. 1999 Oct;17(10):3252-9.
  • Baldini EH, Demetri GD, Fletcher CD, Foran J, Marcus KC, Singer S.Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.Ann Surg. 1999 Jul;230(1):79-86.
  • Baldini EH, DeCamp MM, Katz MS, Berman SM, Swanson SJ, Mentzer SJ, Bueno R, Sugarbaker DJ.Patterns of recurrence and outcome for patients with clinical stage II non-small-cell lung cancer.Am J Clin Oncol. 1999 Feb;22(1):8-14.
  • Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM, DeCamp MM, Swanson SJ, Bueno R, Lukanich JM, Baldini EH, Mentzer SJ.Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.J Thorac Cardiovasc Surg. 1999 Jan;117(1):54-63; discussion 63-5.
  • Monson JM, Stark P, Reilly JJ, Sugarbaker DJ, Strauss GM, Swanson SJ, Decamp MM, Mentzer SJ, Baldini EH.Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma.Cancer. 1998 Mar 1;82(5):842-50.
  • Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini EH, Frei E, Sugarbaker DJ.Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).Lung Cancer. 1997 May;17(1):147-61.
  • Baldini EH, Recht A, Strauss GM, DeCamp MM, Swanson SJ, Liptay MJ, Mentzer SJ, Sugarbaker DJ.Patterns of failure after trimodality therapy for malignant pleural mesothelioma.Ann Thorac Surg. 1997 Feb;63(2):334-8.